Skip to main content

Invokana: Maintaining its Gait

Invokana: Maintaining its Gait

Invokana: Maintaining its Gait

Introduction

Invokana lawsuits have shown further movement in the court proceedings with the approval coming forth for the Plaintiff Fact Sheets along with its protocols details by the U.S. District Court, District of New Jersey. Invokana had recently made it to the news for updating the label regarding increased risk of leg and foot amputations as a new black box warning by the FDA.

Invokana had entered the market with a bang as the first SGLT2 inhibitor approved by the FDA to treat Type 2 diabetes. However, today more than 400 lawsuits are pending in the court, filed by individuals who suffered diabetic ketoacidosis, kidney damage, and other side effects due to its use.

Over the course of time, Neural IT has kept its clients happy by efficient, accurate, and timely delivery of Plaintiff Fact Sheet forms that speak of quality, with a full understanding that this step helps to streamline discovery stage by replacing formal interrogatories in large, complex litigations.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.